List of Tables
Table 1. Global Vascular Endothelial Growth Factor Inhibitor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vascular Endothelial Growth Factor Inhibitor Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vascular Endothelial Growth Factor Inhibitor Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vascular Endothelial Growth Factor Inhibitor Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vascular Endothelial Growth Factor Inhibitor Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vascular Endothelial Growth Factor Inhibitor Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vascular Endothelial Growth Factor Inhibitor Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vascular Endothelial Growth Factor Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vascular Endothelial Growth Factor Inhibitor, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vascular Endothelial Growth Factor Inhibitor, Product Type & Application
Table 12. Global Key Manufacturers of Vascular Endothelial Growth Factor Inhibitor, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vascular Endothelial Growth Factor Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor Inhibitor as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vascular Endothelial Growth Factor Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vascular Endothelial Growth Factor Inhibitor Sales by Region (2020-2025) & (K Units)
Table 18. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Region (2020-2025)
Table 19. Global Vascular Endothelial Growth Factor Inhibitor Sales by Region (2026-2031) & (K Units)
Table 20. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Region (2026-2031)
Table 21. Global Vascular Endothelial Growth Factor Inhibitor Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Region (2020-2025)
Table 23. Global Vascular Endothelial Growth Factor Inhibitor Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Region (2026-2031)
Table 25. North America Vascular Endothelial Growth Factor Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vascular Endothelial Growth Factor Inhibitor Sales by Country (2020-2025) & (K Units)
Table 27. North America Vascular Endothelial Growth Factor Inhibitor Sales by Country (2026-2031) & (K Units)
Table 28. North America Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vascular Endothelial Growth Factor Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vascular Endothelial Growth Factor Inhibitor Sales by Country (2020-2025) & (K Units)
Table 32. Europe Vascular Endothelial Growth Factor Inhibitor Sales by Country (2026-2031) & (K Units)
Table 33. Europe Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vascular Endothelial Growth Factor Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vascular Endothelial Growth Factor Inhibitor Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Vascular Endothelial Growth Factor Inhibitor Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vascular Endothelial Growth Factor Inhibitor Sales (K Units) by Type (2020-2025)
Table 51. Global Vascular Endothelial Growth Factor Inhibitor Sales (K Units) by Type (2026-2031)
Table 52. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type (2020-2025)
Table 53. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type (2026-2031)
Table 54. Global Vascular Endothelial Growth Factor Inhibitor Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vascular Endothelial Growth Factor Inhibitor Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Type (2020-2025)
Table 57. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Type (2026-2031)
Table 58. Global Vascular Endothelial Growth Factor Inhibitor Price (USD/Unit) by Type (2020-2025)
Table 59. Global Vascular Endothelial Growth Factor Inhibitor Price (USD/Unit) by Type (2026-2031)
Table 60. Global Vascular Endothelial Growth Factor Inhibitor Sales (K Units) by Application (2020-2025)
Table 61. Global Vascular Endothelial Growth Factor Inhibitor Sales (K Units) by Application (2026-2031)
Table 62. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application (2020-2025)
Table 63. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application (2026-2031)
Table 64. Global Vascular Endothelial Growth Factor Inhibitor Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vascular Endothelial Growth Factor Inhibitor Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Application (2020-2025)
Table 67. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Application (2026-2031)
Table 68. Global Vascular Endothelial Growth Factor Inhibitor Price (USD/Unit) by Application (2020-2025)
Table 69. Global Vascular Endothelial Growth Factor Inhibitor Price (USD/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Vascular Endothelial Growth Factor Inhibitor Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Novartis Vascular Endothelial Growth Factor Inhibitor Product
Table 79. Novartis Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. AstraZeneca Vascular Endothelial Growth Factor Inhibitor Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Bayer Company Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bayer Vascular Endothelial Growth Factor Inhibitor Product
Table 89. Bayer Recent Developments/Updates
Table 90. Merck Company Information
Table 91. Merck Description and Business Overview
Table 92. Merck Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Merck Vascular Endothelial Growth Factor Inhibitor Product
Table 94. Merck Recent Developments/Updates
Table 95. Genentech Company Information
Table 96. Genentech Description and Business Overview
Table 97. Genentech Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Genentech Vascular Endothelial Growth Factor Inhibitor Product
Table 99. Genentech Recent Developments/Updates
Table 100. Eli Lilly Company Information
Table 101. Eli Lilly Description and Business Overview
Table 102. Eli Lilly Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Eli Lilly Vascular Endothelial Growth Factor Inhibitor Product
Table 104. Eli Lilly Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sanofi Vascular Endothelial Growth Factor Inhibitor Product
Table 109. Sanofi Recent Developments/Updates
Table 110. GlaxoSmithKline Company Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. GlaxoSmithKline Vascular Endothelial Growth Factor Inhibitor Product
Table 114. GlaxoSmithKline Recent Developments/Updates
Table 115. Bristol-Myer Squibb Company Information
Table 116. Bristol-Myer Squibb Description and Business Overview
Table 117. Bristol-Myer Squibb Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bristol-Myer Squibb Vascular Endothelial Growth Factor Inhibitor Product
Table 119. Bristol-Myer Squibb Recent Developments/Updates
Table 120. Boehringer Ingelheim Company Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Boehringer Ingelheim Vascular Endothelial Growth Factor Inhibitor Product
Table 124. Boehringer Ingelheim Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Vascular Endothelial Growth Factor Inhibitor Distributors List
Table 128. Vascular Endothelial Growth Factor Inhibitor Customers List
Table 129. Vascular Endothelial Growth Factor Inhibitor Market Trends
Table 130. Vascular Endothelial Growth Factor Inhibitor Market Drivers
Table 131. Vascular Endothelial Growth Factor Inhibitor Market Challenges
Table 132. Vascular Endothelial Growth Factor Inhibitor Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vascular Endothelial Growth Factor Inhibitor
Figure 2. Global Vascular Endothelial Growth Factor Inhibitor Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vascular Endothelial Growth Factor Inhibitor Market Share by Type: 2024 & 2031
Figure 4. Oral Medications Product Picture
Figure 5. Injections Product Picture
Figure 6. Global Vascular Endothelial Growth Factor Inhibitor Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Vascular Endothelial Growth Factor Inhibitor Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Ambulatory Surgical Centers
Figure 10. Cancer Research Institutes
Figure 11. Global Vascular Endothelial Growth Factor Inhibitor Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Vascular Endothelial Growth Factor Inhibitor Market Size (2020-2031) & (US$ Million)
Figure 13. Global Vascular Endothelial Growth Factor Inhibitor Sales (2020-2031) & (K Units)
Figure 14. Global Vascular Endothelial Growth Factor Inhibitor Average Price (USD/Unit) & (2020-2031)
Figure 15. Vascular Endothelial Growth Factor Inhibitor Report Years Considered
Figure 16. Vascular Endothelial Growth Factor Inhibitor Sales Share by Manufacturers in 2024
Figure 17. Global Vascular Endothelial Growth Factor Inhibitor Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Vascular Endothelial Growth Factor Inhibitor Players: Market Share by Revenue in Vascular Endothelial Growth Factor Inhibitor in 2024
Figure 19. Vascular Endothelial Growth Factor Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Vascular Endothelial Growth Factor Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country (2020-2031)
Figure 22. North America Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country (2020-2031)
Figure 26. Europe Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country (2020-2031)
Figure 27. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Region (2020-2031)
Figure 28. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Region (2020-2031)
Figure 29. Latin America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country (2020-2031)
Figure 30. Latin America Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country (2020-2031)
Figure 31. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country (2020-2031)
Figure 32. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country (2020-2031)
Figure 33. Global Sales Market Share of Vascular Endothelial Growth Factor Inhibitor by Type (2020-2031)
Figure 34. Global Revenue Market Share of Vascular Endothelial Growth Factor Inhibitor by Type (2020-2031)
Figure 35. Global Vascular Endothelial Growth Factor Inhibitor Price (USD/Unit) by Type (2020-2031)
Figure 36. Global Sales Market Share of Vascular Endothelial Growth Factor Inhibitor by Application (2020-2031)
Figure 37. Global Revenue Market Share of Vascular Endothelial Growth Factor Inhibitor by Application (2020-2031)
Figure 38. Global Vascular Endothelial Growth Factor Inhibitor Price (USD/Unit) by Application (2020-2031)
Figure 39. Vascular Endothelial Growth Factor Inhibitor Value Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
